Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Bein

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 28, 2021
Sex-specific differences in plasma levels of FXII, HK, and FXIIa-C1-esterase inhibitor complexes in community-acquired pneumoniaKristin Ehrlich, Jochen Wilhelm, Philipp Markart, et al.
Therapeutic Advances in Hematology|October 21, 2017
Red cell genotyping precision medicine: a conference summaryGregory A Denomme, Waseem Q Anani, Neil D Avent, et al.
Haematologica|March 30, 2019
Glycoprotein V is a relevant immune target in patients with immune thrombocytopeniaRichard Vollenberg, Rabie Jouni, Peter A A Norris, et al.
Critical Care Medicine|April 25, 2008
Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factorThilo Menges, Inke R König, Hamid Hossain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2019
ADAR1 Is Required for Dendritic Cell Subset Homeostasis and Alveolar Macrophage FunctionNelli Baal, Sarah Cunningham, Hannah-Lena Obermann, et al.
The Journal of Investigative Dermatology|September 17, 2023
Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus VulgarisDario Didona, Luca Scarsella, Christoph Hudemann, et al.
Vox Sanguinis|June 22, 2021
Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulationsFrederik Banch Clausen, Åsa Hellberg, Gregor Bein, et al.
NEJM Evidence|January 27, 2026
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and NewbornDerek P de Winter, Kenneth J Moise, Leona E Ling, et al.
The New England Journal of Medicine|August 8, 2024
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and NewbornKenneth J Moise, Leona E Ling, Dick Oepkes, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 28, 2021
Sex-specific differences in plasma levels of FXII, HK, and FXIIa-C1-esterase inhibitor complexes in community-acquired pneumoniaKristin Ehrlich, Jochen Wilhelm, Philipp Markart, et al.
Therapeutic Advances in Hematology|October 21, 2017
Red cell genotyping precision medicine: a conference summaryGregory A Denomme, Waseem Q Anani, Neil D Avent, et al.
Haematologica|March 30, 2019
Glycoprotein V is a relevant immune target in patients with immune thrombocytopeniaRichard Vollenberg, Rabie Jouni, Peter A A Norris, et al.
Critical Care Medicine|April 25, 2008
Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factorThilo Menges, Inke R König, Hamid Hossain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2019
ADAR1 Is Required for Dendritic Cell Subset Homeostasis and Alveolar Macrophage FunctionNelli Baal, Sarah Cunningham, Hannah-Lena Obermann, et al.
The Journal of Investigative Dermatology|September 17, 2023
Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus VulgarisDario Didona, Luca Scarsella, Christoph Hudemann, et al.
Vox Sanguinis|June 22, 2021
Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulationsFrederik Banch Clausen, Åsa Hellberg, Gregor Bein, et al.
NEJM Evidence|January 27, 2026
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and NewbornDerek P de Winter, Kenneth J Moise, Leona E Ling, et al.
The New England Journal of Medicine|August 8, 2024
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and NewbornKenneth J Moise, Leona E Ling, Dick Oepkes, et al.
Pageof 10